Detalhe da pesquisa
1.
Excellent response to anti-CD38 therapy with daratumumab in a patient with severe refractory CANOMAD.
J Neurol Neurosurg Psychiatry
; 95(7): 609-611, 2024 Jun 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38341197
2.
Membrane Proteome-Wide Screening of Autoantibodies in CIDP Using Human Cell Microarray Technology.
Neurol Neuroimmunol Neuroinflamm
; 11(3): e200216, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38484217
3.
mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(6)2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37679040